EGFR and colorectal carcinoma: Cox’s regression analysis of disease-specific survival indicates that detection of EGFR mutations is an independent marker for poor prognosis in CRC with a hazard ratio of 3.639 (Table 3; p = 0.02, CI = 1.221–10.850).